6 recruiting, 3 not yet recruiting, 1 unknown. 5 Phase 2, 4 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Not yet recruiting 1, Unknown 1 |
| Not applicable | 4 | Not yet recruiting 2, Recruiting 2 |
| Phase 3 | 2 | Recruiting 2 |
Follow Stereotactic Body Radiation Therapy (SBRT): new trials by email Literature Review of Stereotactic Body Radiation Therapy (SBRT) trials Research Report on Stereotactic Body Radiation Therapy (SBRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases Stereotactic Body Radiation Therapy (SBRT), Computed Tomography (CT) Simulation, Magnetic Resonance Imaging (MRI) - Spine Metastasis, Stereotactic Body Radiation Therapy (SBRT) | Not applicable | Not yet recruiting | University of California, San Francisco | 50 | 2026-11-01 | 2026-09-15 |
| Efficacy and Safety of Stereotactic Body Radiation Therapy for Spinal Metastases With Bilsky Grade 1c-3 SBRT - Stereotactic Body Radiation Therapy (SBRT), Spinal Metastases | Not applicable | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 50 | 2026-09-03 | 2026-09-09 |
| PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer Ultrahypofractionated Whole-Pelvis Radiotherapy, SBRT-Based Prostate Radiotherapy (No Boost), Ablative Prostate Boost - Prostate Cancer, Brachytherapy | Phase 2 / Phase 3 | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 600 | 2026-03-19 | 2026-07-21 |
| PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer Stereotactic Body Radiotherapy (SBRT) Monotherapy, External Beam Radiotherapy (EBRT) Backbone, High-Dose-Rate Brachytherapy Boost - Prostate Cancer (Adenocarcinoma), Prostate Brachytherapy | Phase 2 / Phase 3 | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 1000 | 2026-03-19 | 2026-07-21 |
| Stereotactic Radiosurgery as Second-line Therapy for Ventricular Tachycardia Stereotactic Arrhythmia Radioablation (STAR), Catheter Ablation - Ventricular Tachycardia, Monomorphic, Ventricular Tachycardia, Sustained | Not applicable | Not yet recruiting | Medical University of Silesia | 150 | 2025-07-01 | 2025-06-12 |
| Practical Geriatric Assessment in Older Adults With Non-Small Cell Lung Cancer Undergoing Stereotactic Body Radiation Therapy Practical Geriatric Assessment - Lung Cancer (NSCLC), Geriatric Assessment | Not applicable | Recruiting | Brigham and Women's Hospital | 64 | 2025-05-26 | 2026-08-25 |
| Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer SBRT, Docetaxel, Cisplatin, Toripalimab, Radical resection surgery - Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC) | Phase 2 | Not yet recruiting | Sun Yat-sen University | 50 | 2025-05-06 | 2025-04-25 |
| SMC Radiation Oncology SABR Cohort for Oligometastasis Stereotactic body radiotherapy (SBRT) - Stereotactic Body Radiation Therapy (SBRT), Oligometastasis | Recruiting | Samsung Medical Center | 60 | 2025-05-01 | 2025-08-13 | |
| The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer Narlumosbart, Stereotactic Body Radiation Therapy - NSCLC, Stereotactic Body Radiation Therapy (SBRT) | Phase 2 | Recruiting | Fudan University | 27 | 2025-02-15 | 2026-09-11 |
| Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma Tislelizumab - Recurrent Nasopharyngeal Carcinoma, Unresectable Nasopharyngeal Carcinoma | Phase 2 | Unknown | Fudan University | 40 | 2019-04-15 | 2022-04-04 |
Prostatic Neoplasms (2) · Adenocarcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1) · Tachycardia, Ventricular (1)
Neoplasms (5) · Neoplasms by Site (5) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Head and Neck Neoplasms (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
Radiosurgery (4) · Androgen Antagonists (2) · Catheter Ablation (1) · Cisplatin (1) · Docetaxel (1) · Drug Therapy (1) · Magnetic Resonance Spectroscopy (1) · Prostaglandins A (1) · Surveys and Questionnaires (1) · tislelizumab (1) · toripalimab (1)
Affidea Nu-med Center of Oncological DIagnostics and Therapy (2) · Fudan University (2) · Brigham and Women's Hospital (1) · Medical University of Silesia (1) · Samsung Medical Center (1) · Sun Yat-sen University (1) · Tianjin Medical University Cancer Institute and Hospital (1) · University of California, San Francisco (1)
China (4) · Poland (3) · United States (2) · South Korea (1)
Mateusz Bilski, MD PhD (1) · Mateusz Bilski, MD, PhD (1) · Steve Braunstein, MD, PhD (1) · Xiaoshen Wang (1)